Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Jun 12, 2024 2:51pm
98 Views
Post# 36085406

RE:Board holdings

RE:Board holdings
LithLover wrote: Riggs owns 12.5 million shares, Tripp 3.8 million, Garth 1 million, Harry 1 million  and Health Clinics 12.5 million.

So Tripp's just gonna let the filing pass, get delisted and file for bankruptcy  Riggs would just let 12.5 million shares at .04 or $500,000 be written off.  Rather than loan the company the money to file?

 


Tripp has had 6 weeks to file, so far nothing. If I had to pick one single word to describe Tripp it would be tendentious

If for the sake of argument he gets the auditors paid before 3 July 2024, what then? Surely the board will not keep this utter incompetent on board? 

There is an old saying that company and fish both smell after 3 days. The same applies after 3 years of trying to get Aristotle to market. It stinks to hgh heaven, Tripp has to go, the sooner the better.
<< Previous
Bullboard Posts
Next >>